| Home Market Dynamics Sector Analysis Company Insights AI Investing Strategies Contact Us Login |
| Amgen is experiencing robust product sales growth, with an 11% increase indicating strong market demand. The company's promising product pipeline, including innovative candidates like MariTide, along with ongoing investments in future product development, further suggests potential for substantial market expansion. Technological advancements are also poised to enhance performance within this sector. However, current setbacks in late-stage studies for key drugs may pose challenges to achieving the desired outcomes. |
| The price action of Amgen (AMGN) is impacted by broad market risk appetite, sector price trend, company-specific performance and market structure. The market sentiment at 0.3 is modestly bullish. Trend sentiment measures the current trend of the stock price, and market sentiment reflects what market participants collectively think where the price will move next.There is no clear direction for AMGN since trend sentiment and market sentiment are at the opposite directions. The positive sentiment force for sector is at 0.5, and the negative at -0.2 on 2025-02-05. The forces of and Valuation Sentiment (-1) will drive down the price. The forces of Stock Price Trend (0), Sector Price Trend (0), Price Level Sentiment (0), Option Sentiment (0), Market Risk Appetite (0), and Sentiment towards Fundamentals (2.9) will drive up the price. The sentiment for Sector Price Trend is calculated based on the price trend of related sector ETF. The sentiment for Option Speculation is calculated from put/call ratio. The Risk Appetite is calculated from Bitcoin price trend. Price Level sentiment is positive when oversold, and negative when overbought. Valuation Sentiment, and Sentimentals towards Fundamentals are extracted from headlines and market commentary. All sentiment scores are normalized on a -10 - +10 scale. The price level reaches 100 at Bollinger upper band, and zero at lower band. |
| AMGN | |||||||||||||
| Date | Attention | Price | Price Level | Change | SMA10 Trend | Trend Sentiment | Hourly Trend | Hourly StdDev | Market Sentiment | Action | P | Fund. | News Sentiment |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-02-05 | 0%(0%) | 0 | 0% | 0.3 | 2.9 | -1 | |||||||
| 2025-01-31 | 0%(0%) | 0 | 0% | 0.2 | 2.4 | -1 | |||||||
| 2025-01-28 | 0%(0%) | 0 | 0% | 0.3 | 2.6 | -1 | |||||||
| 2025-01-16 | 0%(0%) | 0 | 0% | 0.2 | 2.2 | -1 | |||||||
| 2025-01-10 | 0%(0%) | 0 | 0% | 0.2 | 2.2 | -1 | |||||||
| 2024-12-11 | 0%(0%) | 0 | 0% | 0.2 | 2.2 | -1 | |||||||
| 2024-12-06 | 0%(0%) | 0 | 0% | 0.1 | 1.8 | -1 | |||||||
| 2024-11-26 | 0%(0%) | 0 | 0% | 0.2 | 2 | -1 | |||||||
| 2024-11-19 | 0%(0%) | 0 | 0% | 0.2 | 2.1 | -1 | |||||||
| 2024-11-05 | 0%(0%) | 0 | 0% | 0.3 | 2.5 | -1 | |||||||
| Wait action is recommended in three scenarios with either high uncertainty or high risk: 1. The trend sentiment and market sentiment are at the opposite directions. 2. Both trend sentiment and market sentiment are positive, but the price level is elevated. 3. Both trend sentiment and market sentiment are negative, but the price level is depressed. In an uptrend, as an investor, you may want to wait for the pullback to open long position. In a downtrend, the price will likely rebound after huge decline. As an investor, you may want to wait for the rebound to exit long position. | |||||||||||||
| Market sentiment will accelerate the current trend when both trend sentiment and market sentiment are at the same direction. Market sentiment will generate volatility when it's at the opposite direction of the trend sentiment. News sentiment measures the daily emotion of the market. News sentiment may impact the daily price change while market sentiment is a more stable and consistent moving force. | |||||||||||||
| 2025-07-18 17:51:55 The presence of several blockbuster medicines positions Amgen favorably in the market, showcasing its competitive advantages despite some patent expirations. |
| 2025-07-18 17:51:55 Amgen's promising product pipeline, especially with drugs like MariTide, suggests strong potential for future development and market growth. |
| 2025-07-18 17:51:55 The articles detail a regulatory challenge faced by Amgen with the FDA placing a clinical hold on one of their obesity drug candidates, affecting investor sentiment. |
| 2025-07-18 17:51:55 Analysts express positive views on Amgen's future growth prospects due to a strong pipeline and successful label expansions. |
| 2025-07-18 17:51:55 The articles highlight Amgen's strong financial performance, with revenue and earnings exceeding expectations, indicating a robust company earnings status. |